Skip to main content

Advertisement

Log in

Clinical relevance and uptake of core outcome sets in dermatology

  • RESEARCH LETTER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chiarotto A, Ostelo RW, Turk DC et al (2017) Core outcome sets for research and clinical practice. Braz J Phys Ther 21:77. https://doi.org/10.1016/J.BJPT.2017.03.001

    Article  PubMed  PubMed Central  Google Scholar 

  2. Core Outcomes Set Initiative (CS-COUSIN) (2023) Cochrane Skin. https://skin.cochrane.org/core-outcomes-set-initiative-csg-cousin. Accessed 15 Aug 2023

  3. Kottner J, Schmitt J (2018) Core outcome sets in dermatology: next steps. Br J Dermatol 179:549

    Article  CAS  PubMed  Google Scholar 

  4. ImprovedGroup (2023) http://www.improvedgroup.org/. Accessed 13 Oct 2023

Download references

Author information

Authors and Affiliations

Authors

Contributions

AA, and MA wrote the manuscript, VS, MH, MM prepared the table. All authors reviewed the manuscript and collected data.

Corresponding author

Correspondence to Murad Alam.

Ethics declarations

Conflict of interest

Dr. Garg is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Cosmo Pharma, Incyte, Insmed, Janssen, Novartis, Pfizer, Sonoma Biotherapeutics, UCB, Union Therapeutics, Ventyx Biosciences, and Viela Biosciences, and receives honoraria. Dr Garg receives research grants from AbbVie, UCB, National Psoriasis Foundation, and CHORD COUSIN Collaboration (C3). He is the co-copyright holder of the HS-IGA and HiSQOL instruments. Dr Ingram receives a stipend as Editor-in-Chief of the British Journal of Dermatology and an authorship honorarium from UpToDate. He is a consultant for Abbvie, Boehringer Ingelheim, ChemoCentryx, Citryll, Novartis, UCB Pharma, and UNION Therapeutics and has served on advisory boards for Insmed, Kymera Therapeutics, and Viela Bio. He is the co-copyright holder of HiSQOL and Investigator Global Assessment instruments for HS. His department receives income from copyright of the Dermatology Life Quality Instrument (DLQI) and related instruments. He is the Treasurer of the CHORD-COUSIN Collaboration (C3).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, A., Koza, E., Shi, V. et al. Clinical relevance and uptake of core outcome sets in dermatology. Arch Dermatol Res 316, 78 (2024). https://doi.org/10.1007/s00403-023-02814-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-023-02814-z

Navigation